Posted
Aug 31, 2026
Sep 14, 2026
Description: This procurement Special Notice, rather than a grant program, announces the Department of Veterans Affairs’ intent to award Roche Diagnostics Corporation a sole-source bridge contract for viral-load molecular diagnostic testing equipment, supplies, and services. The six-month base period is planned for October 1, 2026 through March 31, 2027, with one six-month option period, supporting continued CPT molecular testing while new analyzers are delivered, installed, and validated at James J. Peters VA Medical Center. The notice is not a request for quotes, but responsible sources may submit capability statements by September 14, 2026 at 12:00 p.m. EDT.
Federal · DC, US
Original attachments and procurement documents tied to this bid.
Federal RFP files are for Starbridge customers only.
You can request RFP files from all other buyer types for free on this site.
Decision makers connected to this RFP from Department of Veterans Affairs.
Adjacent opportunities open for bidding right now.
Posted
Aug 31, 2026
Sep 14, 2026
Provide viral load molecular testing cpt bridge.
Posted
Aug 26, 2026
Sep 10, 2026
A molecular assay which analyzes thyroid fine needle aspiration specimens from patients who have had a previous diagnosis of “atypical cells of undetermined significance” (Bethesda III) or “follicular neoplasm” (Bethesda IV).
CityTX
Posted
Aug 20, 2026
Sep 8, 2026
Provide lab testing wastewater.
Department of Veterans Affairs
FederalDC
Posted
Aug 19, 2026
Sep 10, 2026
The Department of Veterans Affairs, through Network Contract Office 20, seeks rapid syndromic molecular testing reagents for the Seattle VA Medical Center. The procurement covers FDA-approved infectious disease and oncology assays supplied as single-use test cartridges and reagents, including respiratory, gastrointestinal, sexually transmitted infection, and molecular oncology tests. The solicitation is active as of 2026-08-30, with responses due September 10, 2026, at 5:00 PM UTC.